| Literature DB >> 33545985 |
Yi Dong1, Yanli Liu2, Jianguo Yu2, Shixin Qi2, Huijuan Liu2.
Abstract
Entities:
Year: 2021 PMID: 33545985 PMCID: PMC7837830 DOI: 10.1097/MD.0000000000023981
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Figure 1Annual publications and citation bursts analysis. (A) The annual number of publications in DR study from 2010 to 2019. (B) Top 28 keywords with the strongest citation bursts on DR from 2010 to 2019.
Top 10 productive countries in diabetic retinopathy study, 2010–2019.
| Rank | Country | Count (%) | Citations | Total link strengthen |
| 1 | United States | 3280 (27.7) | 79,761 | 2108 |
| 2 | China | 2222 (18.8) | 26,304 | 798 |
| 3 | Japan | 811 (6.9) | 15,670 | 297 |
| 4 | England | 752 (6.4) | 18,476 | 1002 |
| 5 | Germany | 657 (5.5) | 15,655 | 821 |
| 6 | Australia | 640 (5.4) | 17,188 | 966 |
| 7 | India | 578 (4.97) | 9666 | 394 |
| 8 | South Korea | 560 (4.7) | 6779 | 188 |
| 9 | Italy | 544 (4.6) | 12,545 | 575 |
| 10 | Spain | 375 (3.2) | 6439 | 343 |
Figure 2Network visualization map of countries’ collaboration in DR research during the period 2009 to 2018. The size of the node represents the number of publications of the country and the thickness of lines signifies the size of collaboration between the countries. The minimum number of documents of a country was set as 25. Of the 128 countries that were involved in DR research, 52 countries met the threshold.
TOP 10 productive organizations in diabetic retinopathy study, 2010 to 2019.
| Rank | Organization | Country | Count (%) | Citations |
| 1 | University of Melbourne | Australia | 2.13 | 7499 |
| 2 | Shanghai Jiao Tong University | China | 1.82 | 2416 |
| 3 | Johns Hopkins University | USA | 1.76 | 8658 |
| 4 | University of Sydney | Australia | 1.72 | 7147 |
| 5 | National University of Singapore | Singapore | 1.71 | 5809 |
| 6 | University of Wisconsin | USA | 1.57 | 5893 |
| 7 | Sun Yat-Sen University | China | 1.39 | 2644 |
| 8 | Capital Medical University | China | 1.25 | 1707 |
| 9 | Harvard university | USA | 1.21 | 5152 |
| 10 | Singapore National Eye Center | Singapore | 1.09 | 2766 |
Figure 3Network visualization map of main research organizations in DRstudy from 2009 to 2018. The size of each node is determined by the number of publications from each institution. The width of each line represents the strength of links between institutions. The minimum number of documents of an organization was set as 60. Of the 8642 organizations that were involved in DR research, 54 organizations met the threshold.
Top 10 productive authors and co-cited authors in diabetic retinopathy study, 2010 to 2019.
| Rank | Author | Count | Co-cited author | Count |
| 1 | Wong, TY | 173 | Klein, R | 3199 |
| 2 | Klein, R | 79 | Kowluru, RA | 1628 |
| 3 | Lamoureux, EL | 73 | Aiello, LP | 1423 |
| 4 | Mitchell, P | 59 | Wong, TY | 1370 |
| 5 | Bandello, F | 59 | Barber, AJ | 1113 |
| 6 | Kowluru, RA | 58 | Cheung, N | 1060 |
| 7 | Peto, T | 57 | Antonetti, DA | 984 |
| 8 | Simo, R | 56 | Joussen, AM | 885 |
| 9 | Wang, JJ | 55 | Yau, JWY | 785 |
| 10 | Kern, TS | 53 | Spaide, RF | 764 |
Figure 4Co-cited authorship network in DR study from 2009 to 2018. The size of the frame represents the number of publications of the author and the thickness of lines signifies the size of collaboration between the authors. The minimum number of documents of an author was set as 300. Of the 111,933 authors that were involved in DR research, 65 authors met the threshold.
Top 10 main source journals in diabetic retinopathy study, 2010 to 2019.
| Rank | Journal | Country | Count | % of 11,839 |
| 1 | Investigative ophthalmology & Visual Science | United States | 782 | 6.61 |
| 2 | PLOS ONE | United States | 464 | 3.92 |
| 3 | Retina-The Journal of Retinal and Vitreous Diseases | United States | 455 | 3.84 |
| 4 | Ophthalmology | United States | 283 | 2.39 |
| 5 | Acta ophthalmologica | Den Mark | 245 | 2.07 |
| 6 | Graefe's Archives for Clinical and Experimental Ophthalmology | United States | 216 | 1.83 |
| 7 | British Journal of Ophthalmology | England | 201 | 1.70 |
| 8 | American Journal of Ophthalmology | United States | 186 | 1.57 |
| 9 | Scientific Reports | England | 185 | 1.56 |
| 10 | International journal of ophthalmology | China | 176 | 1.49 |
Top 10 co-cited references in Diabetic Retinopathy research, 2010 to 2019.
| Rank | Title | Author | Cluster | Citations |
| 1 | A survey on deep learning in medical image analysis | Litjens, Geert | 4 | 1402 |
| 2 | Global Prevalence and Major Risk Factors of Diabetic Retinopathy | Yau, Joanne W. Y. | 2 | 1389 |
| 3 | Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs | Gulshan, Varun | 4 | 1077 |
| 4 | Diabetic retinopathy | Cheung, Ning | 4 | 1020 |
| 5 | Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema | Elman, Michael J. | 3 | 776 |
| 6 | The RESTORE Study Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy for Diabetic Macular Edema | Mitchell, Paul | 3 | 740 |
| 7 | Ranibizumab for Diabetic Macular Edema Results from 2 Phase III Randomized Trials: RISE and RIDE | Quan Dong Nguyen | 3 | 737 |
| 8 | Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes. | Chew, Emily Y. | 3 | 660 |
| 9 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema | Wells, John A | 3 | 592 |
| 10 | Inflammation in diabetic retinopathy | Tang, Johnny | 1 | 499 |
Figure 5Co-occurrence network of keywords in DR study. The size of the points represents the frequency, and the keywords are grouped into 6 clusters: (Cluster 1-Red) pathogenesis of DR; (Cluster 2-Green) epidemiology and risk factors for DR; (Cluster 3-Brown) treatments for DR; (Cluster 4-Yellow) screening of DR; (Cluster 5-Purple) histopathology of DR; and (Cluster 6-Blue) diagnostic methods for DR. The minimum number of occurrences of a keyword was set as 20. Of the 13,415 keywords that were involved in DR research, 226 keywords met the threshold.
Co-occurrence analysis of keywords. Top 10 keywords in the 6 clusters.
| Cluster 1 Red | Cluster 2 Green | Cluster 3 Brown | Cluster 4 Yellow | Cluster 5 Purple | Cluster 6 Blue |
| diabetes (675) | diabetic retinopathy (2940) | diabetic macular edema (838) | glaucoma (311) | vascular endothelial growth factor (269) | optical coherence tomography (854) |
| retina (524) | diabetes mellitus (497) | proliferative diabetic retinopathy (518) | screening (261) | age-related macular degeneration (195) | optical coherence tomography angiography (229) |
| inflammation (272) | retinopathy (343) | bevacizumab (541) | telemedicine (139) | ranibizumab (179) | cataract (228) |
| angiogenesis (243) | type 2 diabetes (311) | macular edema (459) | ophthalmology (106) | visual acuity (137) | fluorescein angiography (153) |
| oxidative stress (225) | type 2 diabetes mellitus (203) | vitrectomy (292) | diabetic retinopathy (dr) (51) | neovascularization (104) | foveal avascular zone (105) |
| vegf (222) | diabetic nephropathy (179) | anti-vegf (232) | deep learning (95) | choroidal thickness (72) | imaging (104) |
| apoptosis (200) | type 1 diabetes (167) | panretinal photocoagulation (126) | macula (106) | oct (71) | phacoemulsification (83) |
| polymorphism (83) | risk factors (138) | diabetic macular edema (125) | eye (103) | retinal neovascularization (60) | retinal thickness (83) |
| hypoxia (78) | epidemiology (109) | intravitreal injection (177) | retinal imaging (66) | choroidal neovascularization (58) | epiretinal membrane (71) |
| Neurodegeneratio (76) | nephropathy (84) | retinal vein occlusion (161) | classification (70) | aflibercept (54) | retinal vasculature (73) |